The Clinical Value of Tumour Markers in the Management of Ovarian Cancer

This publication has 31 references indexed in Scilit:

• Tumor markers in the management of patients with ovarian cancer
  Cancer Treatment Reviews, 1995
• Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
  JNCI Journal of the National Cancer Institute, 1993
• OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
  Journal of Clinical Oncology, 1993
• Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
  BMJ, 1993
• The management of ovarian carcinoma is improved by the use of cancer-associated serum antigen and CA 125 assays
  Cancer, 1993
• Immunohistochemical detection of CA-125 and carcinoembryonic antigen in ovarian tumors in relation to corresponding preoperative serum levels
  International Journal of Gynecologic Cancer, 1992
• Preoperative discrimination between ovarian carcinoma, non-ovarian gynecological malignancy and benign adnexal masses using serum levels of CA125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA
  International Journal of Gynecologic Cancer, 1992
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990
• Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses
  Gynecologic Oncology, 1990
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981